PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
32100949-4	2020	We report a case of type A IR syndrome with an in-frame INSR heterozygous deletion (DeltaLeu999) that was treated with a combination of conventional therapy and ipragliflozin, a sodium-glucose cotransporter 2 (SGLT2) inhibitor.	ipragliflozin	161-174	insulin receptor	Homo sapiens	56-60